PDCD1 and neoplasm: As for the macrophage-derived EVs, EVs secreted from M1 macrophages have been engineered via electroporation to carry PD-L1 siRNA, which result in the inhibition of PD-1/PD-L1 interactions, exhibiting anti-tumor effects (Figure 5C) [134].